Pharma stocks make strong moves on robust results, positive outlook; Natco zooms 14%
Shares of Natco, Glenmark and Aurobindo Pharma are up 14, 10 and 2 percent respectively in the session.
Read MoreShares of Natco, Glenmark and Aurobindo Pharma are up 14, 10 and 2 percent respectively in the session.
Read MoreSharekhan is bullish on Lumax Auto Technologies has recommended buy rating on the stock with a target price of Rs 540 in its research report dated February 15, 2024.
Read MoreThe long term growth potential is likely “inching higher toward 6.5%, or slightly higher,â€� Santanu Sengupta said in an interview with Bloomberg Television’s Haslinda Amin Friday. He forecast growth at 6.3% for the next fiscal year that starts in April,…
Read More“Last week, I lost a big order to a Polish competitor who does not need to pay increased freight rates,” said Jhunjhunwala, head of Binayak Hi Tech Engineering which ships about 700 containers of machinery tools, industrial castings, and railway…
Read MoreProfitmart is bullish on Hampton Sky Realty has recommended buy rating on the stock with a target price of Rs 70 in its research report dated February 16, 2024.
Read MoreThe HC observed that since the CCI has already decided to hear the pleas against Google on February 21, the petitions have now become infructuous or invalid
Read More